Outlook Therapeutics (OTLK) Equity Ratio (2015 - 2026)
Outlook Therapeutics (OTLK) reported Equity Ratio of 1.32 for Q1 2026, up 22.18% year-over-year from 1.08 in Q1 2025, and up 37.34% quarter-over-quarter from 2.11 in Q4 2025.
Outlook Therapeutics (OTLK) Equity Ratio (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 12 years of Equity Ratio data on file, last reported at 1.32 in Q1 2026.
- Equity Ratio for Q1 2026 came in at 1.32, up 22.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.32 (up 22.18% YoY), and the FY2025 annual result was 1.73, up 31.69% from the prior year.
- Equity Ratio climbed to 1.32 in Q1 2026 per OTLK's latest filing, from 2.11 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.53 in Q1 2022 and troughed at 2.96 in Q4 2024.
- A 5-year average of 1.06 and a median of 1.32 in 2026 frame the typical range for Equity Ratio.
- The sharpest annual moves came in 2022 and 2024: Equity Ratio surged 51.62% in 2022, then slumped 1335.16% in 2024.
- A 5-year view of Equity Ratio shows it stood at 0.25 in 2022, then tumbled by 546.57% to 1.12 in 2023, then slumped by 163.43% to 2.96 in 2024, then rose by 28.53% to 2.11 in 2025, then surged by 37.34% to 1.32 in 2026.
- Business Quant data shows OTLK's Equity Ratio at 1.32 in Q1 2026, 2.11 in Q4 2025, and 1.73 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 191.07 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.98 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 0.04 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.42 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.73 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 0.79 |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | -1.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.32 |
| Dec 31, 2025 | -2.11 |
| Sep 30, 2025 | -1.73 |
| Jun 30, 2025 | -1.66 |
| Mar 31, 2025 | -1.70 |
| Dec 31, 2024 | -2.96 |
| Sep 30, 2024 | -2.54 |
| Jun 30, 2024 | -1.78 |
| Mar 31, 2024 | -2.27 |
| Dec 31, 2023 | -1.12 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | 0.19 |
| Dec 31, 2022 | 0.25 |
| Sep 30, 2022 | 0.31 |
| Jun 30, 2022 | 0.52 |
| Mar 31, 2022 | 0.53 |
| Dec 31, 2021 | 0.62 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.39 |